Neoplasm Treatment Market Players:
- Thermo Fisher Scientific Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Bayer AG
- Merck & Co., Inc.
- Novartis AG
- Abbott Laboratories
- Exelixis, Inc.
- Boehringer Ingelheim GmbH
- Teva Pharmaceutical Industries Ltd.
- F. Hoffmann-La Roche
- Amgen Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of neoplasm treatment is evaluated at USD 263.93 billion.
The global neoplasm treatment market size was worth over USD 241.74 billion in 2025 and is poised to grow at a CAGR of around 10.2%, reaching USD 638.51 billion revenue by 2035.
The North America neoplasm treatment market is expected to capture the largest revenue share by 2035, supported by the escalating incidence of cancer and the strong presence of advanced research institutes coupled with high healthcare spending in the region.
Key players in the market include Thermo Fisher Scientific Inc., Bayer AG, Merck & Co., Inc., Novartis AG, Abbott Laboratories, Exelixis, Inc., Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche, Amgen Inc.
